News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,205 Results
Type
Article (8031)
Company Profile (140)
Press Release (478033)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166935)
Career Advice (305)
Deals (25785)
Drug Delivery (7)
Drug Development (52904)
Employer Resources (14)
FDA (9765)
Job Trends (8577)
News (238419)
Policy (17917)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (492)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33228)
ALS (106)
Alzheimer's disease (991)
Antibody-drug conjugate (ADC) (277)
Approvals (10404)
Artificial intelligence (326)
ASCO (159)
Autoimmune disease (216)
Automation (29)
Bankruptcy (263)
Best Places to Work (6960)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (30)
Breast cancer (519)
Cancer (3727)
Cardiovascular disease (225)
Career advice (245)
Career pathing (1)
CAR-T (177)
CDMO (10)
Celiac Disease (1)
Cell therapy (484)
Cervical cancer (35)
Clinical research (48015)
Collaboration (1273)
Commercialization (3)
Compensation (1519)
Complete response letters (34)
COVID-19 (759)
CRISPR (64)
C-suite (791)
Cystic fibrosis (87)
Data (5815)
Denatured (4)
Depression (103)
Dermatology (67)
Diabetes (350)
Diagnostics (4216)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (158)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73774)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88083)
Executive appointments (710)
FDA (12459)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (940)
Gene editing (126)
Generative AI (9)
Gene therapy (330)
GLP-1 (294)
Government (948)
Grass and pollen (2)
Guidances (281)
Healthcare (9379)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (65)
Immunology and inflammation (101)
Immuno-oncology (61)
Indications (159)
Infectious disease (950)
Inflammatory bowel disease (127)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (260)
Interviews (41)
IPO (12390)
IRA (2)
Job creations (1969)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5198)
Licensing (16)
Liver cancer (45)
Longevity (19)
Lung cancer (521)
Lymphoma (257)
Machine learning (27)
Management (3)
Manufacturing (556)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8702)
Medtech (8858)
Mergers & acquisitions (14451)
Metabolic disorders (718)
mRNA (60)
Multiple sclerosis (106)
NASH (4)
Neurodegenerative disease (224)
Neuropsychiatric disorders (40)
Neuroscience (1860)
NextGen: Class of 2026 (3151)
Non-profit (843)
Obesity (227)
Opinion (10)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (204)
Parkinson's disease (204)
Partnered (12)
Patents (490)
Patient recruitment (523)
Patient selection (1)
Peanut (31)
People (41359)
Peptides (1)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15511)
Phase 2 (21429)
Phase 3 (14464)
Pipeline (7616)
Policy (18)
Postmarket research (1572)
Preclinical (6554)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (194)
Rare diseases (584)
Real estate (3024)
Recruiting (6)
Regulatory (14918)
Reports (23)
Research institute (584)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (49)
Schizophrenia (102)
Series A (158)
Series B (123)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (89)
Sponsored (5)
Startups (2026)
Stomach cancer (3)
Supply chain (51)
Vaccines (333)
Venture capital (17)
Weight loss (74)
Women's health (83)
Date
Last 7 days (372)
Last 30 days (1299)
Last 365 days (19042)
2026 (13363)
2025 (19270)
2024 (23014)
2023 (26553)
2022 (34646)
2021 (37236)
2020 (33509)
2019 (23269)
2018 (17483)
2017 (18798)
2016 (17940)
2015 (24287)
2014 (21700)
2013 (18155)
2012 (20233)
2011 (20453)
2010 (20347)
Location
Africa (229)
Alabama (76)
Alaska (2)
Arizona (309)
Arkansas (11)
Asia (17967)
Australia (2109)
California (12275)
Canada (3218)
China (541)
Colorado (491)
Connecticut (424)
Delaware (211)
Europe (24985)
Florida (1840)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (719)
India (52)
Indiana (320)
Iowa (16)
Japan (415)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1223)
Massachusetts (8056)
Michigan (314)
Minnesota (568)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (119)
New Hampshire (61)
New Jersey (2679)
New Mexico (12)
New York (2879)
North Carolina (1311)
North Dakota (4)
Northern California (6170)
Ohio (288)
Oklahoma (14)
Oregon (16)
Pennsylvania (2290)
Puerto Rico (20)
Rhode Island (30)
South America (408)
South Carolina (77)
South Dakota (1)
Southern California (5105)
Tennessee (122)
Texas (1990)
United States (39790)
Utah (367)
Vermont (1)
Virginia (156)
Washington D.C. (38)
Washington State (954)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
486,205 Results for "srl inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.
January 7, 2026
·
5 min read
Press Releases
Anaergia S.r.l. Expands Scope at Three Biomethane Facilities Being Built for QGM S.á.r.l. in Italy, Increasing Contracts by C$17 Million
March 17, 2026
·
3 min read
Pharm Country
Vela Diagnostics Collaborates with SRL Inc. for Product Distribution in Japan
Vela Diagnostics announced a research collaboration with SRL Inc, a premier Japanese healthcare service company.
October 2, 2023
·
2 min read
Deals
Frontage Laboratories Acquires Accelera S.r.l.'s Bioanalytical and DMPK Businesses
Frontage Laboratories, Inc. today announced that, through its wholly-owned subsidiary Frontage Europe S.r.l., it has completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera).
January 2, 2024
·
5 min read
Pharm Country
Hoth Therapeutics Announces Joint Development Agreement with Wise Systems International SRL to Utilize Artificial Intelligence for Drug Discovery
Hoth Therapeutics, Inc., a patient focused biopharmaceutical company, announced the entry into a joint development agreement with Wise Systems International SRL to leverage artificial intelligence utilizing the BioNeMo AI platform of Nvidia.
June 10, 2024
·
2 min read
Press Releases
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria Químico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
March 25, 2025
·
3 min read
Press Releases
KRTL Holding Group Inc. Announces Milestone Achievement: FDA Registration of Industria Químico Farmaceutica SIGMA CORP. S.R.L.’s Federal Establishment Identifier
January 22, 2025
·
4 min read
Business
ReiThera Srl, The Ragon Institute and IAVI Announce Collaboration to Advance Highly Networked T Cell HIV Vaccine Candidate Towards Phase I Clinical Evaluation
ReiThera Srl, the Ragon Institute of Mass General, MIT, and Harvard, and IAVI are pleased to announce a collaboration to develop a novel HIV vaccine candidate that will be composed of ReiThera’s GRAd vector and HIV T cell epitopes identified by the Ragon Institute, funded by the Bill & Melinda Gates Foundation.
January 22, 2024
·
6 min read
Business
Nanomix Enters into Distribution Agreement for the eLab System with Gepa Srl in Italy
Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care (POC) diagnostics, today announced that it has entered into a distribution agreement with Gepa Srl (“Gepa”), a distributor and supplier of diagnostic products in Italy.
November 29, 2022
·
4 min read
Business
Nerviano Medical Sciences S.r.l. Announces Collaboration and Option to License Agreement with Merck
Nerviano Medical Sciences S.r.l. announced today the signing of a collaboration agreement with licensing option with Merck Healthcare KGaA (Merck), for the next-generation highly selective and brain penetrant PARP1 inhibitor NMS-293.
September 21, 2022
·
5 min read
1 of 48,621
Next
